<DOC>
	<DOC>NCT00798759</DOC>
	<brief_summary>The purpose of this study is to compare two ophthalmic solutions in patients with open-angle glaucoma or ocular hypertension.</brief_summary>
	<brief_title>Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>18 years or older. Diagnosis of openangle glaucoma or ocular hypertension in at least one eye. Intraocular pressure (IOP) controlled with BAK (benzalkonium chloride) preserved IOPlowering medication for 1 year, with last 6 months on XALATANÂ® monotherapy. Best corrected visual acuity of 0.6 logMAR or better in each eye. Other protocoldefined inclusion criteria may apply. Treatment with BAK preserved artificial tears within 30 days of Visit 1. Known or suspected Sjogren's disease. Uncontrolled IOP. History or evidence of infectious or inflammatory ocular conditions. Progressive retinal or optic nerve disease. Ocular laser surgery within 3 months of Visit 1. Keratorefractive ocular laser procedures, corneal surgery or surgery to the corneal surface within 1 year of Visit 1. Current use of punctal plugs or punctal cautery. Use of systemic medications that has not been stable for 30 days prior to Visit 1. Use of contact lens within 30 days of Visit 1. Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Open-angle glaucoma</keyword>
	<keyword>Ocular hypertension</keyword>
</DOC>